Evidence map›Paper›PMID 34351000›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2021

Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration.

Olaitan Okunoye, Laura Horsfall, Louise Marston, Kate Walters, Anette Schrag

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Update: Protective and risk factors for Parkinson disease.Parkinsonism & related disorders · 2024
    Review
  10. Article
  11. Update: Descriptive epidemiology of Parkinson disease.Parkinsonism & related disorders · 2024
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olaitan OkunoyeDepartment of Clinical and Movement Neurosciences, University College London, London, United Kingdom.ORCID 0000-0003-0758-0987
Laura HorsfallDepartment of Primary Care and Population Health, University College London, London, United Kingdom.
Louise MarstonDepartment of Primary Care and Population Health, University College London, London, United Kingdom.
Kate WaltersDepartment of Primary Care and Population Health, University College London, London, United Kingdom.
Anette SchragDepartment of Clinical and Movement Neurosciences, University College London, London, United Kingdom.ORCID 0000-0002-9872-6680
University College London · GB

Funding

Department of HealthWellcome Trust 209207Wellcome Trust 209207/Z/17/Z
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is associated with increased mortality, but little is known about changes over time, and relationship to disease progression.

objectivesTo explore how PD mortality rates have changed over time and their relationship to disease duration and demographics using a large population-based cohort in the UK.

methodsWe included individuals aged 50+ years with a first recording of PD diagnosis and at least two prescriptions of any antiparkinsonian drug actively registered within a general practice from 2006 to 2016 and up to six frequency-matched controls from The Health Improvement Network (THIN) database. We estimated adjusted mortality rates using multivariable Poisson regression.

resultsA total of 10,104 people with a diagnosis of PD and 55,664 people without PD were included. Overall, PD was associated with slightly increased mortality compared to non-PD controls (adjusted mortality rate ratio: 1.14; 95% CI: 1.03 to 1.19). Adjusted mortality rates per 1000 person-years at risk for people with PD approximately doubled in the 5 years following diagnosis from 43 (95% CI: 38 to 48) to 75 (95% CI: 64 to 85). Following adjustments for age, gender, and time since diagnosis, mortality rates between 2007 and 2016 declined more slowly for people with PD (2% per year; 95% CI: 0%-4%) compared to people without PD (5% per year; 95% CI: 3%-6%).

conclusionsWhilst mortality in PD is only slightly increased overall, it gradually increases with advancing disease. There has been a decline in mortality in PD over time, but this decrease was less pronounced than that in the general population. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

Indexed as

Parkinson DiseaseCohort StudiesDisease ProgressionHumansMiddle AgedUnited Kingdomdisease progressionmortalityParkinson's diseaseprimary caresociodemographic factorstrends

Identifiers

PMID34351000
PMCPMC7612920
OpenAlexW3188619557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.